Answer
Leqvio (inclisiran sodium) commonly causes injection-site adverse reactions (8.2%), including pain, redness and rash; these were mild or moderate, transient and resolved without lasting effects.
Sources for this answer
- Leqvio 284 mg solution for injection in pre filled syringeNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.8 Undesirable effects · Version 4Document updated
Sources checked